NDC 10812-130 Neutrogena Clinical Lifting Wrinkle Treatment System
Avobenzone, Homosalate, Octisalate, Octocrylene, And Oxybenzone Cream Topical

Product Information

Product Code10812-130
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Neutrogena Clinical Lifting Wrinkle Treatment System
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Avobenzone, Homosalate, Octisalate, Octocrylene, And Oxybenzone
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Human Otc Drug
Dosage FormCream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route(s) What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Product Labeler Information What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.
Johnson & Johnson Consumer Inc.
Labeler Code10812
FDA Application Number What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
part352
Marketing Category What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
04-15-2010
End Marketing Date What is the End Marketing Date?
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
12-01-2023
Exclude Flag What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".
N
NDC Code Structure

Product Packages

NDC 10812-130-90

Package Description: 1 BOTTLE, PUMP in 1 KIT > 10 mL in 1 BOTTLE, PUMP

Product Details

Neutrogena Clinical Lifting Wrinkle Treatment System is a human over the counter drug product labeled by Johnson & Johnson Consumer Inc.. The generic name of Neutrogena Clinical Lifting Wrinkle Treatment System is avobenzone, homosalate, octisalate, octocrylene, and oxybenzone. The product's dosage form is cream and is administered via topical form.


What are Neutrogena Clinical Lifting Wrinkle Treatment System Active Ingredients?

The following is the list of active ingredients in this product. An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.


* Please review the disclaimer below.

Neutrogena Clinical Lifting Wrinkle Treatment System Labeling and Warnings

FDA filings in the form of structured product labels are documents that include all published material associated whith this product. Product label information includes data like indications and usage generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Otc - When Using



For external use only. Avoid contact with eyes. If contact occurs, flush thoroughly with water. Discontinue use if irritation or rash appear.


Otc - Keep Out Of Reach Of Children



Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.


Active Ingredients



Avobenzone 3%, Homosalate 12%, Octisalate 5%, Octocrylene 5%, Oxybenzone 3%


Inactive Ingredients



Water
Butylene Glycol
C12-15 Alkyl Benzoate
Tetrahydroxypropyl Ethylenediamine
Silica
Cetearyl Alcohol
Cyclopentasiloxane
Dimethicone
Steareth-2
Glyceryl Stearate
Steareth-21
Aluminum Starch Octenylsuccinate
Cetearyl Glucoside
C13-14 Isoparaffin
Dimethicone/Vinyl Dimethicone Crosspolymer
Arachidyl Alcohol
PEG-100 Stearate
Disodium EDTA
Polyacrylamide
Behenyl Alcohol
Acrylates/C10-30 Alkyl Acrylate Crosspolymer
Propylparaben
Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate
Arachidyl Glucoside
Laureth-7
Citric Acid
Benzyl Alcohol
Phenoxyethanol
Methylparaben
Ethylparaben
Fragrance


Questions



1-800-582-4048 or www.neutrogena.com


Principal Display Panel - Kit Carton



NEW

Neutrogena
clinical

lifting wrinkle treatment system

visibly smoothes wrinkles and firms
for a resilient, youthful look

STARTER SYSTEM
SPF 30 EYE

helloplex®

with
ion2complex

gel serum    +  spf 30 activating  +  
cream
eye activating
cream

GEL SERUM 0.5 FL OZ (14mL) • SPF 30 ACTIVATING CREAM 0.33 FL OZ (10mL)
EYE ACTIVATING CREAM 0.17 FL OZ (5mL)


* Please review the disclaimer below.